← Back to search
3j9f

Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C

Method: ELECTRON MICROSCOPY Dmax: 154.3 Å Quality: REASONABLE
▼

1. Protein Identity and Related Structures Protein Identity & Related Structures

Protein VP1

OrganismNot specified

UniProt P03300

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Other combination Heteromer Protein × 420 其他Polymer 360 PDB declaration: 420-meric（420） Consistent with protein copy count Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) Poliovirus receptor × 60 （P15151） Poliovirus receptor × 60 （P15151） Poliovirus receptor × 60 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 120 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 60 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 120 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 60 PLM PALMITIC ACID × 60 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
2 Other combination Heteromer Protein × 7 其他Polymer 6 PDB declaration: heptameric（7） Consistent with protein copy count Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) Poliovirus receptor × 1 （P15151） Poliovirus receptor × 1 （P15151） Poliovirus receptor × 1 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 PLM PALMITIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
3 Other combination Heteromer Protein × 35 其他Polymer 30 PDB declaration: 35-meric（35） Consistent with protein copy count Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) Poliovirus receptor × 5 （P15151） Poliovirus receptor × 5 （P15151） Poliovirus receptor × 5 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 5 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 5 PLM PALMITIC ACID × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
4 Other combination Heteromer Protein × 42 其他Polymer 36 PDB declaration: 42-meric（42） Consistent with protein copy count Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) Poliovirus receptor × 6 （P15151） Poliovirus receptor × 6 （P15151） Poliovirus receptor × 6 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 6 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 6 PLM PALMITIC ACID × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
5 Other combination Heteromer Protein × 7 其他Polymer 6 PDB declaration: heptameric（7） Consistent with protein copy count Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) Poliovirus receptor × 1 （P15151） Poliovirus receptor × 1 （P15151） Poliovirus receptor × 1 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 PLM PALMITIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 3J9F Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Not recorded SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Not recorded SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Not recorded SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa） Fragment：VIRUS PROTOMER
Chain 2 69–340（272 aa） Fragment：VIRUS PROTOMER
Chain 3 341–578（238 aa） Fragment：VIRUS PROTOMER
Not recorded SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
Resolution 2.90 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 598–880（283 aa）
Chain 2 73–340（268 aa）
Chain 3 341–575（235 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 598–880（283 aa）
Chain 2 73–340（268 aa）
Chain 3 341–575（235 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 598–880（283 aa）
Chain 2 73–340（268 aa）
Chain 3 341–575（235 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 598–880（283 aa）
Chain 2 73–340（268 aa）
Chain 3 341–575（235 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 598–880（283 aa）
Chain 2 73–340（268 aa）
Chain 3 341–575（235 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 240 PDB declaration: 240-MERIC
Chain 1 579–880（302 aa） Fragment：RESIDUES 579-880
Chain 2 69–340（272 aa） Fragment：RESIDUES 69-340
Chain 3 341–577（237 aa） Fragment：RESIDUES 341-577
Chain 4 1–68（68 aa） Fragment：RESIDUES 1-68
Not recorded PLM PALMITIC ACID × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
Resolution 2.20 Å
1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric
Chain 1 579–880（302 aa） Fragment：RESIDUES 579-880
Chain 2 69–340（272 aa） Fragment：RESIDUES 69-340
Chain 3 341–577（237 aa） Fragment：RESIDUES 341-577
Chain 4 1–68（68 aa） Fragment：RESIDUES 1-68
Not recorded PLM PALMITIC ACID × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
Resolution 2.20 Å
1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 20 PDB declaration: eicosameric
Chain 1 579–880（302 aa） Fragment：RESIDUES 579-880
Chain 2 69–340（272 aa） Fragment：RESIDUES 69-340
Chain 3 341–577（237 aa） Fragment：RESIDUES 341-577
Chain 4 1–68（68 aa） Fragment：RESIDUES 1-68
Not recorded PLM PALMITIC ACID × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
Resolution 2.20 Å
1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric
Chain 1 579–880（302 aa） Fragment：RESIDUES 579-880
Chain 2 69–340（272 aa） Fragment：RESIDUES 69-340
Chain 3 341–577（237 aa） Fragment：RESIDUES 341-577
Chain 4 1–68（68 aa） Fragment：RESIDUES 1-68
Not recorded PLM PALMITIC ACID × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
Resolution 2.20 Å
1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric
Chain 1 579–880（302 aa） Fragment：RESIDUES 579-880
Chain 2 69–340（272 aa） Fragment：RESIDUES 69-340
Chain 3 341–577（237 aa） Fragment：RESIDUES 341-577
Chain 4 1–68（68 aa） Fragment：RESIDUES 1-68
Not recorded PLM PALMITIC ACID × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
Resolution 2.20 Å
1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein homooligomer Homooligomer；Protein × 120 PDB declaration: 120-meric
Chain 1 579–880（302 aa） Fragment：RESIDUES 579-880
Chain 2 69–340（272 aa） Fragment：RESIDUES 69-340
Chain 3 341–577（237 aa） Fragment：RESIDUES 341-577
Chain 4 1–68（68 aa） Fragment：RESIDUES 1-68
Not recorded PLM PALMITIC ACID × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
Resolution 2.20 Å
1L1N POLIOVIRUS 3C PROTEINASE Deposited 2002-02-19 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1565–1747（183 aa） Fragment：Residues 1565-1747
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5；293 K；ammonium sulfate, glycerol, mercaptoethanol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.10 Å R-free 0.259
1L1N POLIOVIRUS 3C PROTEINASE Deposited 2002-02-19 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 1565–1747（183 aa） Fragment：Residues 1565-1747
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5；293 K；ammonium sulfate, glycerol, mercaptoethanol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.10 Å R-free 0.259
1NG7 The Solution Structure of the Soluble Domain of Poliovirus 3A Protein Deposited 2002-12-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1456–1514（59 aa） Fragment：Poliovirus 3A-N
Chain B 1456–1514（59 aa） Fragment：Poliovirus 3A-N
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 7；25 K；Ionic strength (raw mmCIF value) 20 mM potassium phosphate, 50 mM NaCl；Pressure ambient
NMR measurement conditions pH 7；25 K；Ionic strength (raw mmCIF value) 10 mM tris, 50 mM NaCl；Pressure ambient
NMR sample composition 1-3 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 100% D2O | 100% D2O
NMR sample composition 1-3 mM 3A-N U-99% 15N; 20mM phosphate buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
NMR sample composition 1.5 mM 3A-N NA; 1.5 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 100% D2O | 100% D2O
NMR sample composition 2 mM 3A-N U-99% 15N; 10 mM tris buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
NMR sample composition 1-3 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
Resolution not provided
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 420 PDB declaration: 420-MERIC
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–575（235 aa）
Chain 4 1–68（68 aa）
Not recorded MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–575（235 aa）
Chain 4 1–68（68 aa）
Not recorded MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 35 PDB declaration: 35-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–575（235 aa）
Chain 4 1–68（68 aa）
Not recorded MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 42 PDB declaration: 42-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–575（235 aa）
Chain 4 1–68（68 aa）
Not recorded MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–575（235 aa）
Chain 4 1–68（68 aa）
Not recorded MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；pH 7.
Resolution 2.90 Å
1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-MERIC
Chain 0 1–340（340 aa）
Chain 1 579–880（302 aa）
Chain 3 341–578（238 aa）
Not recorded MYR MYRISTIC ACID × 60 SPH SPHINGOSINE × 60 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain 0 1–340（340 aa）
Chain 1 579–880（302 aa）
Chain 3 341–578（238 aa）
Not recorded MYR MYRISTIC ACID × 1 SPH SPHINGOSINE × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric
Chain 0 1–340（340 aa）
Chain 1 579–880（302 aa）
Chain 3 341–578（238 aa）
Not recorded MYR MYRISTIC ACID × 5 SPH SPHINGOSINE × 5 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric
Chain 0 1–340（340 aa）
Chain 1 579–880（302 aa）
Chain 3 341–578（238 aa）
Not recorded MYR MYRISTIC ACID × 6 SPH SPHINGOSINE × 6 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain 0 1–340（340 aa）
Chain 1 579–880（302 aa）
Chain 3 341–578（238 aa）
Not recorded MYR MYRISTIC ACID × 1 SPH SPHINGOSINE × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein homooligomer Homooligomer；Protein × 90 PDB declaration: 90-meric
Chain 0 1–340（340 aa）
Chain 1 579–880（302 aa）
Chain 3 341–578（238 aa）
Not recorded MYR MYRISTIC ACID × 30 SPH SPHINGOSINE × 30 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
1RA6 Poliovirus Polymerase Full Length Apo Structure Deposited 2003-10-31 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase (residue 1748-2208)
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.00 Å R-free 0.247
1RA7 Poliovirus Polymerase with GTP Deposited 2003-10-31 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase (residue 1748-2208)
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) GTP GUANOSINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.35 Å R-free 0.259
1RAJ Poliovirus Polymerase with a 68 residue N-terminal truncation Deposited 2003-10-31 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1816–2208（393 aa） Fragment：RNA-directed RNA polymerase
Mutation：L446A, R455D No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium formate, sodium chloride, HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.50 Å R-free 0.262
1RDR POLIOVIRUS 3D POLYMERASE Deposited 1998-04-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa）
Not recorded CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.6；pH 6.6
Resolution 2.40 Å R-free 0.274
1TQL POLIOVIRUS POLYMERASE G1A MUTANT Deposited 2004-06-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa）
Mutation：G1A, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.30 Å R-free 0.262
1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.90 Å
1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.90 Å
1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.90 Å
1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.90 Å
1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.90 Å
1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Not recorded J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.90 Å
1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 420 PDB declaration: 420-MERIC
Chain 1 649–880（232 aa） Fragment：residues 649-880
Chain 2 96–332（237 aa） Fragment：residues 96-332
Chain 3 390–571（182 aa） Fragment：residues 390-571
Chain 5 341–352（12 aa） Fragment：residues 341-352
Chain 6 354–389（36 aa） Fragment：residues 354-389
Chain 7 81–94（14 aa） Fragment：residues 81-94
Chain 8 620–630（11 aa） Fragment：residues 620-630
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE；Plunge freezing into liquid ethane
Resolution 11.00 Å
1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric
Chain 1 649–880（232 aa） Fragment：residues 649-880
Chain 2 96–332（237 aa） Fragment：residues 96-332
Chain 3 390–571（182 aa） Fragment：residues 390-571
Chain 5 341–352（12 aa） Fragment：residues 341-352
Chain 6 354–389（36 aa） Fragment：residues 354-389
Chain 7 81–94（14 aa） Fragment：residues 81-94
Chain 8 620–630（11 aa） Fragment：residues 620-630
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE；Plunge freezing into liquid ethane
Resolution 11.00 Å
1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 35 PDB declaration: 35-meric
Chain 1 649–880（232 aa） Fragment：residues 649-880
Chain 2 96–332（237 aa） Fragment：residues 96-332
Chain 3 390–571（182 aa） Fragment：residues 390-571
Chain 5 341–352（12 aa） Fragment：residues 341-352
Chain 6 354–389（36 aa） Fragment：residues 354-389
Chain 7 81–94（14 aa） Fragment：residues 81-94
Chain 8 620–630（11 aa） Fragment：residues 620-630
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE；Plunge freezing into liquid ethane
Resolution 11.00 Å
1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 42 PDB declaration: 42-meric
Chain 1 649–880（232 aa） Fragment：residues 649-880
Chain 2 96–332（237 aa） Fragment：residues 96-332
Chain 3 390–571（182 aa） Fragment：residues 390-571
Chain 5 341–352（12 aa） Fragment：residues 341-352
Chain 6 354–389（36 aa） Fragment：residues 354-389
Chain 7 81–94（14 aa） Fragment：residues 81-94
Chain 8 620–630（11 aa） Fragment：residues 620-630
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE；Plunge freezing into liquid ethane
Resolution 11.00 Å
1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric
Chain 1 649–880（232 aa） Fragment：residues 649-880
Chain 2 96–332（237 aa） Fragment：residues 96-332
Chain 3 390–571（182 aa） Fragment：residues 390-571
Chain 5 341–352（12 aa） Fragment：residues 341-352
Chain 6 354–389（36 aa） Fragment：residues 354-389
Chain 7 81–94（14 aa） Fragment：residues 81-94
Chain 8 620–630（11 aa） Fragment：residues 620-630
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE；Plunge freezing into liquid ethane
Resolution 11.00 Å
2BBP NMR structures of the peptide linked to the genome (VPg) of poliovirus Deposited 2005-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1544–1565（22 aa） Fragment：residues 1-22
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 7.2；283 K；Ionic strength (raw mmCIF value) 10 mM；Pressure 1
NMR sample composition 3.7 mM peptide, 10 mM Na phosphate buffer, pH 7.2, DSS, 10% D20, 90% H2O | 10% D20, 90% H2O
Resolution not provided
2IJD Crystal Structure of the Poliovirus Precursor Protein 3CD Deposited 2006-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain 1 1565–2208（644 aa）
Mutation：E55A, D58A, E63A, C147A, L629D, R638D ZN ZINC ION × 2 SO4 SULFATE ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2 M ammonium sulfate, 0.1 M HEPES, 0.3% Jeffamine M600, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.40 Å R-free 0.231
2IJD Crystal Structure of the Poliovirus Precursor Protein 3CD Deposited 2006-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain 2 1565–2208（644 aa）
Mutation：E55A, D58A, E63A, C147A, L629D, R638D ZN ZINC ION × 2 SO4 SULFATE ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2 M ammonium sulfate, 0.1 M HEPES, 0.3% Jeffamine M600, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.40 Å R-free 0.231
2IJF Crystal Structure of the Poliovirus RNA-Dependent RNA Polymerase Fidelity Mutant 3Dpol G64S Deposited 2006-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa）
Mutation：G64S, L446D, R455D No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2M sodium acetate, 0.1 M HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.00 Å R-free 0.244
2ILY Crystal structure of poliovirus polymerase complexed with ATP and Mg2+ Deposited 2006-10-03 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase, residues 461-1748
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) NA SODIUM ION × 1 ATP ADENOSINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.60 Å R-free 0.250
2ILZ Crystal structure of poliovirus polymerase complexed with GTP and Mn2+ Deposited 2006-10-03 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase, residues 1748-2208
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) MN MANGANESE (II) ION × 2 NA SODIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.50 Å R-free 0.255
2IM0 Crystal structure of poliovirus polymerase complexed with CTP and Mg2+ Deposited 2006-10-03 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase, residues 1748-2208
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) NA SODIUM ION × 1 CTP CYTIDINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.25 Å R-free 0.260
2IM1 Crystal structure of poliovirus polymerase complexed with CTP and Mn2+ Deposited 2006-10-03 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase, residues 1748-2208
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) MN MANGANESE (II) ION × 3 NA SODIUM ION × 1 CTP CYTIDINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.50 Å R-free 0.268
2IM2 Crystal structure of poliovirus polymerase complexed with UTP and Mg2+ Deposited 2006-10-03 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase, residues 1748-2208
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) NA SODIUM ION × 1 UTP URIDINE 5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.35 Å R-free 0.267
2IM3 Crystal structure of poliovirus polymerase complexed with UTP and Mn2+ Deposited 2006-10-03 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1748–2208（461 aa） Fragment：RNA-directed RNA polymerase, residues 1748-2208
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) MN MANGANESE (II) ION × 2 NA SODIUM ION × 1 UTP URIDINE 5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.60 Å R-free 0.269
2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 240 PDB declaration: 240-MERIC
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Chain 4 1–68（68 aa）
Not recorded SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.88 Å
2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Chain 4 1–68（68 aa）
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.88 Å
2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 20 PDB declaration: eicosameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Chain 4 1–68（68 aa）
Not recorded SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.88 Å
2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Chain 4 1–68（68 aa）
Not recorded SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.88 Å
2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Chain 4 1–68（68 aa）
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.88 Å
2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 6 Protein homooligomer Homooligomer；Protein × 120 PDB declaration: 120-meric
Chain 1 579–880（302 aa）
Chain 2 69–340（272 aa）
Chain 3 341–578（238 aa）
Chain 4 1–68（68 aa）
Not recorded SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.88 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 599–881（283 aa）
Chain 2 74–341（268 aa）
Chain 3 342–576（235 aa）
Chain 4 2–69（68 aa）
Not recorded SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 599–881（283 aa）
Chain 2 74–341（268 aa）
Chain 3 342–576（235 aa）
Chain 4 2–69（68 aa）
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 599–881（283 aa）
Chain 2 74–341（268 aa）
Chain 3 342–576（235 aa）
Chain 4 2–69（68 aa）
Not recorded SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 599–881（283 aa）
Chain 2 74–341（268 aa）
Chain 3 342–576（235 aa）
Chain 4 2–69（68 aa）
Not recorded SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 599–881（283 aa）
Chain 2 74–341（268 aa）
Chain 3 342–576（235 aa）
Chain 4 2–69（68 aa）
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 647–881（235 aa）
Chain 4 97–341（245 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions blot for 3 secs；Cryogen ETHANE
Resolution 10.00 Å
3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 420 PDB declaration: 420-MERIC
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Not recorded SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 11.10 Å
3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 11.10 Å
3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 35 PDB declaration: 35-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Not recorded SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 11.10 Å
3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 42 PDB declaration: 42-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Not recorded SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 11.10 Å
3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Not recorded SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 11.10 Å
3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 9.10 Å
3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 9.10 Å
3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 9.10 Å
3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 9.10 Å
3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
Resolution 9.10 Å
3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
Resolution 5.50 Å
3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
Resolution 5.50 Å
3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
Resolution 5.50 Å
3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
Resolution 5.50 Å
3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
Resolution 5.50 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Other combination Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Other combination Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Other combination Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Other combination Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Other combination Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
Resolution 5.60 Å
3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
Resolution 5.60 Å
3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
Resolution 5.60 Å
3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
Resolution 5.60 Å
3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
Resolution 5.60 Å
3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.70 Å
3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.70 Å
3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.70 Å
3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.70 Å
3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.70 Å
3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.20 Å
3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.20 Å
3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.20 Å
3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.20 Å
3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.20 Å
3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.60 Å
3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.60 Å
3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.60 Å
3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.60 Å
3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 4.60 Å
3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 3.80 Å
3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 3.80 Å
3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 3.80 Å
3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 3.80 Å
3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–578（237 aa） Fragment：UNP residues 342-578
Chain 4 2–69（68 aa） Fragment：UNP residues 2-69
Non-standard monomer：Yes (specific site not provided by mmCIF) PLM PALMITIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer 145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions 4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
Resolution 3.80 Å
4DCD 1.6A resolution structure of PolioVirus 3C Protease Containing a covalently bound dipeptidyl inhibitor Deposited 2012-01-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1566–1748（183 aa） Fragment：unp residues 1566-1748
Not recorded DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1 K36 (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 6.5；298 K；30% (w/v) PEG 5000 MME, 100 mM MES, 200 mM ammonium sulfate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
Resolution 1.69 Å R-free 0.189
4K4S Poliovirus polymerase elongation complex (r3_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric
Chain A 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D ZN ZINC ION × 1 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；sitting drop, temperature 289K, VAPOR DIFFUSION, SITTING DROP
Resolution 2.40 Å R-free 0.245
4K4S Poliovirus polymerase elongation complex (r3_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric
Chain E 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D ZN ZINC ION × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；sitting drop, temperature 289K, VAPOR DIFFUSION, SITTING DROP
Resolution 2.40 Å R-free 0.245
4K4T Poliovirus polymerase elongation complex (r4_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric
Chain A 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D GOL GLYCEROL × 2 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；0.16 M MgCl2, 0.08 M Tris-HCl, 24% (w/v) PEG 4000, 20% (v/v) glycerol and directly frozen for data collection , VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.75 Å R-free 0.262
4K4T Poliovirus polymerase elongation complex (r4_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric
Chain E 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D GOL GLYCEROL × 2 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；0.16 M MgCl2, 0.08 M Tris-HCl, 24% (w/v) PEG 4000, 20% (v/v) glycerol and directly frozen for data collection , VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.75 Å R-free 0.262
4K4U Poliovirus polymerase elongation complex (r5_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric
Chain A 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D, C290M SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), pH 8.5-9.0, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.85 Å R-free 0.276
4K4U Poliovirus polymerase elongation complex (r5_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric
Chain E 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D, C290M SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), pH 8.5-9.0, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.85 Å R-free 0.276
4K4V Poliovirus polymerase elongation complex (r5+1_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Other combination Monomer；Protein × 1 PDB declaration: trimeric
Chain A 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D, C290M No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27% (v/v) xylitol with dCTP prior to freezing, pH pH 8.5-9.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.63 Å R-free 0.273
4K4V Poliovirus polymerase elongation complex (r5+1_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Other combination Monomer；Protein × 1 PDB declaration: trimeric
Chain E 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D, C290M SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27% (v/v) xylitol with dCTP prior to freezing, pH pH 8.5-9.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.63 Å R-free 0.273
4K4W Poliovirus polymerase elongation complex (r5+2_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: trimeric
Chain A 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D, C290A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol with CTP prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.69 Å R-free 0.256
4K4W Poliovirus polymerase elongation complex (r5+2_form) Deposited 2013-04-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: trimeric
Chain E 1749–2209（461 aa） Fragment：unp residues 1749-2209
Mutation：L446D, C290A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol with CTP prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
Resolution 2.69 Å R-free 0.256
4NLO Poliovirus Polymerase - C290I Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：C290I, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.20 Å R-free 0.251
4NLP Poliovirus Polymerase - C290V Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：C290V, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.20 Å R-free 0.248
4NLQ Poliovirus Polymerase - C290F Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：C290F, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 7 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.30 Å R-free 0.245
4NLR Poliovirus Polymerase - C290S Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：C290S, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 6 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.00 Å R-free 0.240
4NLS Poliovirus Polymerase - S288A Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：S288A (+L446D,R455D in Thumb) Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 3 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.00 Å R-free 0.256
4NLT Poliovirus Polymerase - S291P Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：S291P , L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 4 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions Hanging drop；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid (pH 7.0) and 2 mM DTT, Hanging drop, temperature 289K
Resolution 2.50 Å R-free 0.256
4NLU Poliovirus Polymerase - G289A Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：G289A, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 6 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.10 Å R-free 0.246
4NLV Poliovirus Polymerase - G289A/C290F Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：G289A,C290F, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 8 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.30 Å R-free 0.240
4NLW Poliovirus Polymerase - G289A/C290I Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：G289A, C290I, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.10 Å R-free 0.242
4NLX Poliovirus Polymerase - G289A/C290V Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：G289A, C290V, L446D, 455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.60 Å R-free 0.236
4NLY Poliovirus Polymerase - C290E Loop Mutant Deposited 2013-11-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：C290E, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.30 Å R-free 0.239
4R0E Crystal Structure of the Poliovirus RNA-Dependent RNA Polymerase Low-Fidelity Mutant 3Dpol H273R Deposited 2014-07-30 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1749–2209（461 aa）
Mutation：H273R, L446D, R455D No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 7；293 K；Mixed equal volumes of protein 10mg/ml in buffer (5mM Tris pH 7.5, 200mM NaCl, 0.1mM EDTA, 2mM DTT) and reservoir solution (2M Na Acetate, 0.1 M Na Cacodylate pH 6.8) prior to vapor diffusion, VAPOR DIFFUSION, temperature 293K
Resolution 3.00 Å R-free 0.218
5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric
Chain 1 636–858（223 aa） Fragment：UNP residues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-572
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 636–858（223 aa） Fragment：UNP residues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-572
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric
Chain 1 636–858（223 aa） Fragment：UNP residues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-572
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric
Chain 1 636–858（223 aa） Fragment：UNP residues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-572
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 636–858（223 aa） Fragment：UNP residues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-572
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric
Chain 1 636–858（223 aa） Fragment：UNP reisdues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 636–858（223 aa） Fragment：UNP reisdues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric
Chain 1 636–858（223 aa） Fragment：UNP reisdues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric
Chain 1 636–858（223 aa） Fragment：UNP reisdues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 636–858（223 aa） Fragment：UNP reisdues 636-858
Chain 2 70–338（269 aa） Fragment：UNP residues 70-338
Chain 3 342–572（231 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.80 Å
5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.80 Å
5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.80 Å
5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.80 Å
5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain 1 650–858（209 aa） Fragment：UNP residues 650-858
Chain 2 70–337（268 aa） Fragment：UNP residues 70-337
Chain 3 342–571（230 aa） Fragment：UNP residues 342-571
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.80 Å
5Z3Q Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom) Deposited 2018-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric
Chain B 1243–1456（214 aa） Fragment：UNP residues 1243-1456
Chain C 1243–1456（214 aa） Fragment：UNP residues 1243-1456
Chain D 1243–1456（214 aa） Fragment：UNP residues 1243-1456
Chain E 1243–1456（214 aa） Fragment：UNP residues 1243-1456
Mutation：E207A, K209A,R149A Mutation：E207A, K209A,R149A Mutation：E207A, K209A,R149A Mutation：E207A, K209A,R149A ZN ZINC ION × 4 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
Resolution 2.54 Å R-free 0.265
5Z3Q Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom) Deposited 2018-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1243–1456（214 aa） Fragment：UNP residues 1243-1456
Mutation：E207A, K209A,R149A ZN ZINC ION × 1 PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
Resolution 2.54 Å R-free 0.265
5Z3Q Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom) Deposited 2018-01-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain H 1243–1456（214 aa） Fragment：UNP residues 1243-1456
Mutation：E207A, K209A,R149A ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
Resolution 2.54 Å R-free 0.265
6HLV Crystal structure of human ACBD3 GOLD domain in complex with 3A protein of poliovirus-1 (L24A mutant) Deposited 2018-09-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1457–1514（58 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；12,5% w/v PEG 4000, 20% v/v 1,2,6-hexanetriol, 4% v/v tert-butanol, 1 mM rubidium chloride, 1 mM strontium chloride, 1 mM cesium acetate, 1 mM barium acetate, 100 mM GlyGly/AMPD pH 8.5
Resolution 2.50 Å R-free 0.241
6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 180 PDB declaration: 180-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.90 Å
6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.90 Å
6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 15 PDB declaration: pentadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.90 Å
6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.90 Å
6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.90 Å
6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 180 PDB declaration: 180-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 15 PDB declaration: pentadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 180 PDB declaration: 180-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 15 PDB declaration: pentadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–70（69 aa） Fragment：UNP residues 2-70
Non-standard monomer：Yes (specific site not provided by mmCIF) No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–70（69 aa） Fragment：UNP residues 2-70
Non-standard monomer：Yes (specific site not provided by mmCIF) No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–70（69 aa） Fragment：UNP residues 2-70
Non-standard monomer：Yes (specific site not provided by mmCIF) No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–70（69 aa） Fragment：UNP residues 2-70
Non-standard monomer：Yes (specific site not provided by mmCIF) No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain 1 580–881（302 aa） Fragment：UNP residues 580-881
Chain 2 70–341（272 aa） Fragment：UNP residues 70-341
Chain 3 342–579（238 aa） Fragment：UNP residues 342-579
Chain 4 2–70（69 aa） Fragment：UNP residues 2-70
Non-standard monomer：Yes (specific site not provided by mmCIF) No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 360 PDB declaration: 360-meric
Chain 1 600–881（282 aa）
Chain 2 77–341（265 aa）
Chain 4 2–69（68 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.13 Å
8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain 1 600–881（282 aa）
Chain 2 77–341（265 aa）
Chain 4 2–69（68 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.13 Å
8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 1 600–881（282 aa）
Chain 2 77–341（265 aa）
Chain 4 2–69（68 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.13 Å
8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 36 PDB declaration: 36-meric
Chain 1 600–881（282 aa）
Chain 2 77–341（265 aa）
Chain 4 2–69（68 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.13 Å
8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain 1 600–881（282 aa）
Chain 2 77–341（265 aa）
Chain 4 2–69（68 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.13 Å
9EYY Poliovirus type 1 (strain Mahoney) native conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system. Deposited 2024-04-09 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric
Chain A 580–881（302 aa）
Chain B 2–341（340 aa）
Chain C 342–579（238 aa）
Mutation：VP1 H248P Mutation：VP2 T94A, VP2 D126E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L PLM PALMITIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE；3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
Resolution 3.30 Å
9EZ0 Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system. Deposited 2024-04-10 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric
Chain A 580–881（302 aa）
Chain B 2–341（340 aa）
Chain C 342–579（238 aa）
Mutation：VP1 H248P Mutation：VP2 T94A, VP2 D126E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE；3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
Resolution 3.30 Å
9F0K Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a mammalian expression system Deposited 2024-04-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric
Chain A 580–881（302 aa）
Chain B 2–341（340 aa）
Chain C 342–579（238 aa）
Mutation：VP1 H248P Mutation：VP2 T25A, VP2 D57E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE；3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
Resolution 3.00 Å
9F3Q Poliovirus type 1 (strain Mahoney) stabilised virus-like particle (PV1 SC6b) in complex with GPP3 and GSH. Deposited 2024-04-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric
Chain A 580–881（302 aa）
Chain B 2–341（340 aa）
Chain C 342–579（238 aa）
Mutation：VP1 H248P Mutation：VP2 T25A, VP2 D57E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L YM2 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE × 60 GSH Glutathione × 60 ELECTRON MICROSCOPY
cryo-EM buffer pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE；3-4 ul of sample blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
Resolution 2.75 Å
9FQ2 Poliovirus 3C protease in H32 spacegroup Deposited 2024-06-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1566–1748（183 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；Shotgun ECO screen, well B9 1.6M Sodium citrate tribasic dihydrate
Resolution 2.37 Å R-free 0.258
9FQ2 Poliovirus 3C protease in H32 spacegroup Deposited 2024-06-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 1566–1748（183 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；Shotgun ECO screen, well B9 1.6M Sodium citrate tribasic dihydrate
Resolution 2.37 Å R-free 0.258
9WAG Yeast-expressed polio type 1 expanded virus-like particles Deposited 2025-08-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 183 PDB declaration: 183-meric
Chain A 580–881（302 aa）
Chain B 70–341（272 aa）
Chain C 342–579（238 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.95 Å
9WAH Yeast-expressed polio type 1 stabilized virus-like particles Deposited 2025-08-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 240 PDB declaration: 240-meric
Chain F 1–69（69 aa）
Chain H 70–341（272 aa）
Chain I 342–579（238 aa）
Chain J 580–881（302 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.43 Å
9WAI Yeast-expressed polio type 1 stablized virus-like particles with 3G10 Fab Deposited 2025-08-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 714 PDB declaration: 1068-meric
Chain B 70–341（272 aa）
Chain C 342–579（238 aa）
Chain D 580–881（302 aa）
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.60 Å

80 other PDB entries and 246 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name POLG_POL1M
Isoform —
PDB entities 1, 2, 3, 4
Chains and sequence ranges Author chain 1； PDBConstruct 1–302； UniProt 580–881 Author chain 2； PDBConstruct 1–272； UniProt 70–341 Author chain 3； PDBConstruct 1–238； UniProt 342–579 Author chain 4； PDBConstruct 2–69； UniProt 2–69

Poliovirus receptor

OrganismNot specified

UniProt P15151

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Other combination Heteromer Protein × 420 其他Polymer 360 PDB declaration: 420-meric（420） Consistent with protein copy count Chain 7； UniProt 28–143 Chain 8； UniProt 142–243 Chain 9； UniProt 242–333 Fragment：SEE REMARK 999 Protein VP1 × 60 （P03300） Protein VP2 × 60 （P03300） Protein VP3 × 60 （P03300） Protein VP4 × 60 （P03300） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 120 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 60 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 120 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 60 PLM PALMITIC ACID × 60 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
2 Other combination Heteromer Protein × 7 其他Polymer 6 PDB declaration: heptameric（7） Consistent with protein copy count Chain 7； UniProt 28–143 Chain 8； UniProt 142–243 Chain 9； UniProt 242–333 Fragment：SEE REMARK 999 Protein VP1 × 1 （P03300） Protein VP2 × 1 （P03300） Protein VP3 × 1 （P03300） Protein VP4 × 1 （P03300） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 PLM PALMITIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
3 Other combination Heteromer Protein × 35 其他Polymer 30 PDB declaration: 35-meric（35） Consistent with protein copy count Chain 7； UniProt 28–143 Chain 8； UniProt 142–243 Chain 9； UniProt 242–333 Fragment：SEE REMARK 999 Protein VP1 × 5 （P03300） Protein VP2 × 5 （P03300） Protein VP3 × 5 （P03300） Protein VP4 × 5 （P03300） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 5 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 5 PLM PALMITIC ACID × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
4 Other combination Heteromer Protein × 42 其他Polymer 36 PDB declaration: 42-meric（42） Consistent with protein copy count Chain 7； UniProt 28–143 Chain 8； UniProt 142–243 Chain 9； UniProt 242–333 Fragment：SEE REMARK 999 Protein VP1 × 6 （P03300） Protein VP2 × 6 （P03300） Protein VP3 × 6 （P03300） Protein VP4 × 6 （P03300） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 6 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 6 PLM PALMITIC ACID × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å
5 Other combination Heteromer Protein × 7 其他Polymer 6 PDB declaration: heptameric（7） Consistent with protein copy count Chain 7； UniProt 28–143 Chain 8； UniProt 142–243 Chain 9； UniProt 242–333 Fragment：SEE REMARK 999 Protein VP1 × 1 （P03300） Protein VP2 × 1 （P03300） Protein VP3 × 1 （P03300） Protein VP4 × 1 （P03300） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 PLM PALMITIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY cryo-EM vitrification conditions：Cryogen ETHANE Resolution 9.00 Å

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 3J9F Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain R 28–329（302 aa） Fragment：THREE EXTRACELLULAR DOMAINS OF CD155
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain R 28–329（302 aa） Fragment：THREE EXTRACELLULAR DOMAINS OF CD155
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain R 28–329（302 aa） Fragment：THREE EXTRACELLULAR DOMAINS OF CD155
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain R 28–329（302 aa） Fragment：THREE EXTRACELLULAR DOMAINS OF CD155
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain R 28–329（302 aa） Fragment：THREE EXTRACELLULAR DOMAINS OF CD155
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4 DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
Resolution 22.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 420 PDB declaration: 420-MERIC
Chain R 28–329（302 aa）
Chain S 28–329（302 aa）
Chain T 28–329（302 aa）
Not recorded MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric
Chain R 28–329（302 aa）
Chain S 28–329（302 aa）
Chain T 28–329（302 aa）
Not recorded MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 35 PDB declaration: 35-meric
Chain R 28–329（302 aa）
Chain S 28–329（302 aa）
Chain T 28–329（302 aa）
Not recorded MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 42 PDB declaration: 42-meric
Chain R 28–329（302 aa）
Chain S 28–329（302 aa）
Chain T 28–329（302 aa）
Not recorded MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric
Chain R 28–329（302 aa）
Chain S 28–329（302 aa）
Chain T 28–329（302 aa）
Not recorded MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 15.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 8.00 Å
3EPD CryoEM structure of poliovirus receptor bound to poliovirus type 3 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 1 Protein heterocomplex Heteromer；Protein × 360 PDB declaration: 360-MERIC
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPD CryoEM structure of poliovirus receptor bound to poliovirus type 3 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 2 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPD CryoEM structure of poliovirus receptor bound to poliovirus type 3 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 3 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPD CryoEM structure of poliovirus receptor bound to poliovirus type 3 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 4 Protein heterocomplex Heteromer；Protein × 36 PDB declaration: 36-meric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPD CryoEM structure of poliovirus receptor bound to poliovirus type 3 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 5 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 60 MYR MYRISTIC ACID × 60 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 5 MYR MYRISTIC ACID × 5 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 6 MYR MYRISTIC ACID × 6 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric
Chain R 30–242（213 aa） Fragment：Poliovirus receptor CD155 D1D2
Mutation：N105D, N120S, N188Q, N218Q, N237S SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 1 MYR MYRISTIC ACID × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 9.00 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Other combination Heteromer；Protein × 300 PDB declaration: 300-meric
Chain 7 1–417（417 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Other combination Heteromer；Protein × 5 PDB declaration: pentameric
Chain 7 1–417（417 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Other combination Heteromer；Protein × 25 PDB declaration: 25-meric
Chain 7 1–417（417 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Other combination Heteromer；Protein × 30 PDB declaration: 30-meric
Chain 7 1–417（417 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3J8F Cryo-EM reconstruction of poliovirus-receptor complex Deposited 2014-10-20 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Other combination Heteromer；Protein × 5 PDB declaration: pentameric
Chain 7 1–417（417 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM buffer PBS；pH 7；PBS
cryo-EM vitrification conditions Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane.
Resolution 3.70 Å
3UDW Crystal structure of the immunoreceptor TIGIT in complex with Poliovirus receptor (PVR/CD155/necl-5) D1 domain Deposited 2011-10-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain C 28–145（118 aa） Fragment：PVR, UNP residues 28-145
Chain D 28–145（118 aa） Fragment：PVR, UNP residues 28-145
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5.5；298 K；0.1 M Ammonium acetate 0.1 M Bis-Tris pH 5.5 17% PEG 10000, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.90 Å R-free 0.287
3URO Poliovirus receptor CD155 D1D2 Deposited 2011-11-22 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain R 29–243（215 aa） Fragment：poliovirus receptor CD155 D1D2 (UNP Residues 29-243)
Mutation：N105D, N120S, N188Q, N218Q, N237S No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8.5；298 K；100 mM MgSO4, 6.8 M NH4NO3, 100 mM Tris buffer, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 3.50 Å R-free 0.341
3URO Poliovirus receptor CD155 D1D2 Deposited 2011-11-22 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain R 29–243（215 aa） Fragment：poliovirus receptor CD155 D1D2 (UNP Residues 29-243)
Mutation：N105D, N120S, N188Q, N218Q, N237S No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8.5；298 K；100 mM MgSO4, 6.8 M NH4NO3, 100 mM Tris buffer, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 3.50 Å R-free 0.341
4FQP Crystal structure of human Nectin-like 5 full ectodomain (D1-D3) Deposited 2012-06-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Other combination Monomer；Protein × 1 PDB declaration: monomeric
Chain A 28–334（307 aa） Fragment：ectodomain (D1-D3, UNP residues 28-334)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 9；293.15 K；55% v/v tacsimate, 0.1 M Bicine, pH 9.0, with additional 10% tacsimate as cryoprotectant, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K
Resolution 3.60 Å R-free 0.272
6ARQ Crystal structure of CD96 (D1) bound to CD155/necl-5 (D1-3) Deposited 2017-08-23 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Other combination Heteromer；Protein × 2 PDB declaration: dimeric
Chain D 28–334（307 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；32% (v/v) Jeffamine ED-2001 0.1M HEPES pH7.3
Resolution 2.88 Å R-free 0.252
6ISC complex structure of mCD226-ecto and hCD155-D1 Deposited 2018-11-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 28–145（118 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.1 M Tris (pH 8.0), 0.15 M ammonium sulfate, and 15% (w/v) PEG4000
Resolution 2.20 Å R-free 0.265
6O3O Structure of human DNAM-1 (CD226) bound to nectin-like protein-5 (necl-5) Deposited 2019-02-27 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Other combination Heteromer；Protein × 4 PDB declaration: tetrameric
Chain C 28–334（307 aa）
Chain D 28–334（307 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；20% PEG3350, 0.18M K2SO4, 10mM EDTA
Resolution 2.80 Å R-free 0.231

12 other PDB entries and 37 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name PVR_HUMAN
Isoform —
PDB entities 5, 6, 7
Chains and sequence ranges Author chain 7； PDBConstruct 1–116； UniProt 28–143 Author chain 8； PDBConstruct 1–102； UniProt 142–243 Author chain 9； PDBConstruct 1–92； UniProt 242–333

The page prioritizes protein identity, the current assembly, associated components, oligomeric state and cross-PDB links. Chain mapping and sequence ranges are retained as data evidence. Internal IDs, import timestamps and assembly operation expressions are maintenance fields and are not shown here.

SAXS scattering curve SAXS Profile

SAXS profile for 3j9f

P(r) Distance Distribution P(r) Distribution

P(r) distribution for 3j9f
Download Download
▼

2. Structure Basics 2. Structure Basics

Entry ID entry_id3j9f
Deposition date deposition_date2015-01-15
Structure title titlePoliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Keywords keywordsdeglycosylated receptor, picornavirus, PVR, CD155, enterovirus, cell entry, VIRUS-CELL ADHESION complex; VIRUS/CELL ADHESION
Experimental Method methodELECTRON MICROSCOPY
▼

3. SAXS Parameters (CRYSOL theoretical calculation) 3. SAXS Parameters (CRYSOL)

Radius of gyration Rg (Guinier) rg_guinier40.59 Å
Radius of gyration Rg (electron density) rg_electron41.12 Å
Forward intensity I(0) i0267979000.00
Molecular weight molecular_weight131980.0 kDa
Excluded volume excluded_volume165000 ų
Envelope volume envelope_volume229830 ų
Hydration-shell volume shell_volume50332 ų
Envelope diameter envelope_diameter165.5 Å
Shell Rg shell_rg42.22 Å
Envelope Rg envelope_rg43.71 Å
Shape Rg shape_rg41.09 Å
Total Rg total_rg41.27 Å
Total atoms total_atoms9281
Residues n_residues1159
Spherical-harmonic order n_harmonics20
q range q_range— – 0.5000 Å−1
Data points n_points101
Shell type shell_typedirectional
Solvent electron density solvent_density0.3340 e/ų
Shell contrast contrast_shell0.0300 e/ų
CRYSOL version crysol_version4.1.3
▼

4. P(r) Distance Distribution (GNOM inversion) 4. P(r) Analysis (GNOM)

Maximum dimension Dmax dmax154.3 Å
Rg (real space) rg_real41.26 Å
Rg uncertainty (real space) rg_real_error1.77 Å
I(0) (real space) i0_real2.6800e+08
I(0) uncertainty (real space) i0_real_error5.1500e+06
Rg (reciprocal space) rg_reciprocal40.60 Å
I(0) (reciprocal space) i0_reciprocal267800000.0000
Solution quality estimate total_estimate0.7188
Solution quality rating solution_quality REASONABLE a REASONABLE solution
P(r) peaks n_peaks2
Primary peak position r_peak_primary43.5 Å
Skewness Skewness skewness0.928
Kurtosis Kurtosis kurtosis0.585
Angular range angular_range— – 0.1950 Å−1
Current regularization parameter α current_alpha0.0000
Highest regularization parameter α highest_alpha25350000.0000
Real-space data points n_real_points40
GNOM version gnom_version4.1.3
Quality Criteria quality_criteria AN1: 0.000; Oscil: 0.344; Stabil: 1.000; Sysdev: 1.000; Positv: 1.000; Valcen: 0.538; Smooth: 0.770
▶

5. Crystallography and Experiment 5. Crystallography & Experiment

▶

6. Entities and Polymers Entities & Polymers (13)

▶

8. Citations (1)

▶

9. Files and Curves (10)